PaceMate® is attending HRX 2026 on September 19, 2026, at the PaceMate booth to discuss cardiac electrophysiology datasets, algorithmic capability, and real-world clinical adoption.
Published
Signal category
Presence & Recognition
Quote
“On September 19, PaceMate® joins Dr. Camille Frazier-Mills, MD MHS FACC FAHA, Dr. Anne Kroman, Dr. Gregory Marcus, Lisa Roelle, Sean Shoffstall, Dr. Benjamin Steinberg, and Dr. Gene Fu at HRX 2026 to take these questions head-on.”
— PaceMate® team
Company
PaceMate®
The Market-leading Cardiac Clinical Operations Platform Built to Put Patients First.
- Industry
- Hospitals and Health Care
- Location
- Clearwater, US
- Company size
- 223 employees
PaceMate is the market-leading, tech-enabled cardiac device monitoring platform serving integrated delivery networks and academic health systems nationwide. EHR-agnostic and vendor-neutral, PaceMate unifies every major device manufacturer and EHR into one intelligent platform, giving clinical teams the workflow flexibility, population visibility, and patient-level intelligence to deliver exceptional care at scale. PaceMate manages more than 2.3 million patients and is backed by the industry’s only research-grade cardiac dataset built on discrete device, EHR, and operational data. Learn more at PaceMate.com.
Founded 2015